Perkins Capital Management Inc Abb Vie Inc. Transaction History

Perkins Capital Management Inc

$102 Million
Q3 2024

A detailed history of Perkins Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 6,558 shares of ABBV stock, worth $1.18 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

6,558

Previous 7,983 17.85%

Holding current value

$1.18 Million

Previous $1.37 Million 5.41%

% of portfolio

1.27%

Previous 1.35%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $233,472 - $284,045	-1,425 Reduced 17.85%	6,558 $1.3 Million
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $81,264 - $94,899	-525 Reduced 6.17%	7,983 $1.37 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $103,883 - $118,365	-650 Reduced 7.1%	8,508 $1.55 Million
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $233,920 - $263,449	-1,700 Reduced 15.66%	9,158 $1.42 Million
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $20,038 - $23,197	-150 Reduced 1.36%	10,858 $1.62 Million
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $66,255 - $82,450	-500 Reduced 4.34%	11,008 $1.48 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $14,461 - $16,654	-100 Reduced 0.86%	11,508 $1.83 Million
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $55,965 - $64,188	-417 Reduced 3.47%	11,608 $1.56 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $30,939 - $39,147	-288 Reduced 2.34%	12,025 $1.63 Million
Q1 2021 Apr 28, 2021	BUY	$102.3 - $112.62 $12,787 - $14,077	125 Added 1.03%	12,313 $1.33 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $72,441 - $97,803	-900 Reduced 6.88%	12,188 $1.31 Million
Q3 2020 Oct 28, 2020	SELL	$85.91 - $100.83 $107,387 - $126,037	-1,250 Reduced 8.72%	13,088 $1.15 Million
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $12,900 - $19,558	-200 Reduced 1.38%	14,338 $1.09 Million
Q4 2019 Feb 03, 2020	SELL	$72.13 - $90.25 $176,718 - $221,112	-2,450 Reduced 14.42%	14,538 $1.29 Million
Q3 2019 Oct 23, 2019	BUY	$62.98 - $75.72 $380,273 - $457,197	6,038 Added 55.14%	16,988 $1.29 Million
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $13,140 - $16,796	200 Added 1.86%	10,950 $796,000
Q1 2019 Apr 22, 2019	BUY	$77.14 - $90.79 $829,255 - $975,992	10,750 New	10,750 $866,000
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $1.87 Million - $2.5 Million	-20,300 Closed	0 $0
Q4 2017 Jan 26, 2018	BUY	$89.56 - $98.21 $67,170 - $73,657	750 Added 3.84%	20,300 $1.96 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $1.37 Million - $1.74 Million	19,550	19,550 $1.74 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.

Account

Perkins Capital Management Inc Abb Vie Inc. Transaction History